ALC
Alcon Inc.NYSEHealthcare$74.56-1.26%ClosedMarket Cap: $36.34B
As of 2026-04-06
Valuation
P/E (TTM)
37.08
PEG
—
P/B
1.66
P/S
3.49
EV/EBITDA
21.10
DCF Value
$83.32
FCF Yield
4.7%
Div Yield
0.4%
Margins & Returns
Gross Margin
54.8%
Operating Margin
13.1%
Net Margin
9.4%
ROE
4.4%
ROA
7.4%
ROIC
3.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.72B | 54.2% | $313.0M | $217.0M | $0.44 | — |
| FY 2025 | $10.40B | 55.2% | $1.36B | $980.0M | $1.98 | $0.33 |
| Q3 2025 | $2.61B | 55.8% | $332.0M | $237.0M | $0.48 | — |
| Q2 2025 | $2.60B | 53.5% | $247.0M | $176.0M | $0.35 | $0.33 |
| Q1 2025 | $2.47B | 55.9% | $468.0M | $350.0M | $0.70 | — |
| Q4 2024 | $2.50B | 55.4% | $395.0M | $284.0M | $0.57 | — |
| FY 2024 | $9.91B | 55.6% | $1.41B | $1.02B | $2.05 | $0.26 |
| Q3 2024 | $2.45B | 55.9% | $332.0M | $263.0M | $0.53 | — |
| Q2 2024 | $2.50B | 55.0% | $318.0M | $223.0M | $0.45 | $0.26 |
| Q1 2024 | $2.46B | 56.2% | $368.0M | $248.0M | $0.50 | — |
| Q4 2023 | $2.35B | 54.8% | $208.0M | $427.0M | $0.87 | — |
| FY 2023 | $9.46B | 55.5% | $1.04B | $974.0M | $1.96 | $0.24 |